| MeSH term | MeSH ID | Detail |
|---|---|---|
| Delayed Graft Function | D051799 | 2 associated lipids |
| Uterine Cervical Dysplasia | D002578 | 2 associated lipids |
| Venous Insufficiency | D014689 | 2 associated lipids |
| Cytomegalovirus Retinitis | D017726 | 2 associated lipids |
| Telangiectasis | D013684 | 2 associated lipids |
| Still's Disease, Adult-Onset | D016706 | 2 associated lipids |
| IgA Deficiency | D017098 | 2 associated lipids |
| Incontinentia Pigmenti | D007184 | 2 associated lipids |
| Vitiligo | D014820 | 2 associated lipids |
| Hypopigmentation | D017496 | 2 associated lipids |
| Eye Infections, Fungal | D015821 | 2 associated lipids |
| Tumor Lysis Syndrome | D015275 | 2 associated lipids |
| Rectal Fistula | D012003 | 2 associated lipids |
| Hidradenitis Suppurativa | D017497 | 2 associated lipids |
| Molluscum Contagiosum | D008976 | 2 associated lipids |
| Pruritus Ani | D011538 | 2 associated lipids |
| Deglutition Disorders | D003680 | 2 associated lipids |
| Discitis | D015299 | 2 associated lipids |
| Fox-Fordyce Disease | D005588 | 2 associated lipids |
| Collagen Diseases | D003095 | 2 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gérard C et al. | Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach. | 2014 | AAPS J | pmid:24526611 |
| Sy SK et al. | A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation. | 2013 | AAPS J | pmid:23990505 |
| Herskovitz J et al. | Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure. | 2017 | AAPS J | pmid:28070711 |
| Tremblay S and Alloway RR | Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. | 2017 | AAPS J | pmid:28717926 |
| Bush WW | Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. | 1999 | AACN Clin Issues | pmid:10578712 |
| pmid:25901935 | ||||
| pmid:11334064 | ||||
| pmid: | ||||
| pmid:28951508 | ||||
| pmid:28761977 |